|
|
|
|
|
|
|
|
|
|
open access
Therapy related acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS) have been classically linked to alkylating agents and topoisomerase inhibitors. They constitute about 1% of all AMLs. There is less evidence on association of taxanes (paclitaxel and docetaxel) with these myeloid neoplasms.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.